RedHill Biopharma Ltd.

NASDAQ: RDHL · Real-Time Price · USD
1.37
-0.02 (-1.44%)
At close: Aug 15, 2025, 3:59 PM
1.39
1.36%
After-hours: Aug 15, 2025, 06:45 PM EDT

RedHill Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.62M 5.57M 19.97M 29.47M
Short-Term Investments
n/a 790.04K 15K 8.53M
Long-Term Investments
n/a 147K 150K 16.17M
Other Long-Term Assets
148K 41.00 150K 16.17M
Receivables
3.57M 3.29M 37.88M 32.52M
Inventory
3.65M 4.39M 11.01M 14.81M
Other Current Assets
n/a 790K 16M n/a
Total Current Assets
11.91M 16.14M 85.9M 89.15M
Property-Plant & Equipment
437K 1.18M 7.19M 4.22M
Goodwill & Intangibles
5.55M 5.58M 65.63M 71.64M
Total Long-Term Assets
6.13M 6.91M 72.97M 92.04M
Total Assets
18.04M 23.05M 158.87M 181.19M
Account Payables
7.86M 3.28M 4.23M 11.66M
Deferred Revenue
n/a n/a n/a 37.31M
Short-Term Debt
n/a n/a 115.22M n/a
Other Current Liabilities
11.31M 11.48M 49.65M 34.37M
Total Current Liabilities
22.22M 19.24M 197.45M 81.47M
Long-Term Debt
n/a n/a n/a 83.62M
Other Long-Term Liabilities
500K 1.28M 3.37M 4.65M
Total Long-Term Liabilities
503K 1.74M 9.82M 90.84M
Total Liabilities
22.73M 20.98M 207.27M 172.31M
Total Debt
356K 1.17M 122.69M 87.81M
Common Stock
35.04M 21.44M 2.83M 1.5M
Retained Earnings
-414.8M -407.74M -433.86M -367.87M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
-4.68M 2.07M -48.4M 8.88M
Total Investments
n/a 147K 15K 8.53M